학술논문
MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis – JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib – Preliminary Data From the MANIFEST Study
Document Type
Article
Author
Source
In: Clinical Lymphoma, Myeloma and Leukemia , Proceedings of the Society of Hematologic Oncology 2022 Annual Meeting. (Clinical Lymphoma, Myeloma and Leukemia, October 2022, 22:S335-S336)
Subject
Language
English
ISSN
21522669
21522650
21522650